mhurhangee/ep-ind-claims huggingface dataset:
A roller for use in circular fabric knitting machines characterized in that said roller comprises • a main shaft providing rigidity for the roller, • at least one bearing groove which is formed on said main shaft and allows the bearings to rotate, • a distance adjustment member and bearings which are arranged respectively in said bearing grooves, • a roll open on both ends which is made of cloth or similar materials, • and grooved strips which are attached into said cloth roll in a way that each of them will correspond to one of the bearing grooves in order to house the bearings when the cloth roll is slid and attached on the main shaft for winding the fabric thereupon and after that the main shaft is pulled and removed from the cloth roll so that the cloth roll shrinks and can be taken from the wound fabric roll after removing the main shaft from the cloth roll. • a main shaft providing rigidity for the roller, • at least one bearing groove which is formed on said main shaft and allows the bearings to rotate, • a distance adjustment member and bearings which are arranged respectively in said bearing grooves, • a roll open on both ends which is made of cloth or similar materials, • and grooved strips which are attached into said cloth roll in a way that each of them will correspond to one of the bearing grooves in order to house the bearings when the cloth roll is slid and attached on the main shaft for winding the fabric thereupon and after that the main shaft is pulled and removed from the cloth roll so that the cloth roll shrinks and can be taken from the wound fabric roll after removing the main shaft from the cloth roll.
An uplink transmission method comprising the steps of: receiving, by a terminal, first configuration information at a first-time-domain position, receiving second configuration information at a second-time-domain position, wherein the first configuration information indicates frequency-domain resource information for an uplink shortened Transmission Time Interval, sTTI, transmission, which is performed by the terminal at a third-time-domain position, and the second configuration information indicates scheduling information for the uplink sTTI transmission, which is performed by the terminal at the third-time-domain position; and, performing, by the terminal, the uplink sTTI transmission at the third-time-domain position, according to the first and second configuration information; wherein the first configuration information carries first indication information, which indicates the third-time-domain position. receiving, by a terminal, first configuration information at a first-time-domain position, receiving second configuration information at a second-time-domain position, wherein the first configuration information indicates frequency-domain resource information for an uplink shortened Transmission Time Interval, sTTI, transmission, which is performed by the terminal at a third-time-domain position, and the second configuration information indicates scheduling information for the uplink sTTI transmission, which is performed by the terminal at the third-time-domain position; and, performing, by the terminal, the uplink sTTI transmission at the third-time-domain position, according to the first and second configuration information; wherein the first configuration information carries first indication information, which indicates the third-time-domain position.
A process for diagnosing the presence of an mucopolysaccharidosis IIIB (MPS IIIB) disorder in an individual, the process comprising the steps of: a) generating a biomarker comprising of one or more non-reducing end oligosaccharides, wherein the biomarker is a saturated oligosaccharide and is generated by treating a purified population of heparan sulfates isolated from a biological sample from the individual, with digesting glycosaminoglycan lyases, wherein prior to lyase treatment, the biomarker is not present in abundance in samples from individuals with the MPS IIIB disorder relative to individuals without the MPS IIIB disorder, and b) using an analytical instrument to detect the presence of and/or measure the amount of the biomarker produced and displaying or recording the presence of or a measure of a population of the biomarker, wherein the presence and/or amount of the biomarker is utilized to determine the presence of the MPS IIIB disorder, wherein the digesting glycosaminoglycan lyases comprise heparin lyase I, heparin lyase II and heparin lyase III, and wherein the biomarker is selected from trisaccharides according to Formula V [GlcNAc-IdoA-GlcN(Ac) n](SO 3 R) p wherein n is 0-1 and p is 0-3; trisaccharides according to Formula VI [GlcNAc-GlcA-GlcN(Ac) n](SO 3 R) p wherein n is 0-1 and p is 0-2; and trisaccharides according to Formula XVI GlcA-GlcNAc-GlcA. a) generating a biomarker comprising of one or more non-reducing end oligosaccharides, wherein the biomarker is a saturated oligosaccharide and is generated by treating a purified population of heparan sulfates isolated from a biological sample from the individual, with digesting glycosaminoglycan lyases, wherein prior to lyase treatment, the biomarker is not present in abundance in samples from individuals with the MPS IIIB disorder relative to individuals without the MPS IIIB disorder, and b) using an analytical instrument to detect the presence of and/or measure the amount of the biomarker produced and displaying or recording the presence of or a measure of a population of the biomarker, wherein the presence and/or amount of the biomarker is utilized to determine the presence of the MPS IIIB disorder, wherein the digesting glycosaminoglycan lyases comprise heparin lyase I, heparin lyase II and heparin lyase III, and wherein the biomarker is selected from trisaccharides according to Formula V [GlcNAc-IdoA-GlcN(Ac) n](SO 3 R) p wherein n is 0-1 and p is 0-3; trisaccharides according to Formula VI [GlcNAc-GlcA-GlcN(Ac) n](SO 3 R) p wherein n is 0-1 and p is 0-2; and trisaccharides according to Formula XVI GlcA-GlcNAc-GlcA.
Method of activating passenger safety means (140, 150) of a vehicle, the method comprising: - reading in a roll rate of the vehicle; and - triggering the passenger safety means when, at a first time, at least one roll rate value is present, which exhibits a positive sign and is larger than a roll rate positive threshold value and when, at a second time after the first time, at least one roll rate value is present, which exhibits a negative sign and is smaller than a roll rate negative threshold value. - reading in a roll rate of the vehicle; and - triggering the passenger safety means when, at a first time, at least one roll rate value is present, which exhibits a positive sign and is larger than a roll rate positive threshold value and when, at a second time after the first time, at least one roll rate value is present, which exhibits a negative sign and is smaller than a roll rate negative threshold value.
Surgical suture system for tissue repair and reattachment of torn tissue to a tissue substrate or medical, veterinary or dental implant, the system comprising an elongated flexible suture having a plurality of longitudinally spaced protuberances along a length thereof a tissue restraint/suture capture having a central locking aperture for receiving a suture member of the suture passed therethrough for longitudinal movement of the suture in only a forwardly direction through the locking aperture, and a plurality of flex arms defined by adjacent radially extending radial slots, characterized in that each of the radial slots terminates at the outer end thereof in a slot relief hole and that each of the flex arms is further defined by an elongated flex arm slot and that each inner corner of the flex arm slots is formed in proximity to one of the slot relief holes, such that the spacing between the relief holes and the inner corners substantially influences the overall flexibility of the flex arm.
Composite panel comprising at least 4 layers, each layer containing at least one tape comprising a thermoplastic polymer selected from ultra high molecular weight polyethylene and polyamide, wherein the tape has a tensile strength of at least 1.2 GPa measured as specified in ASTM D882 at 20°C on a tape with a width of 2 mm using a gauge length of 131 mm and a crosshead speed of 50mm/min, and an areal density of between 5 and 250 g/m 2, and an adhesive in contact with said layer, whereby the amount of the adhesive in contact with one side of the at least one layer is between 0.2 and 15 g/m 2, characterized in that the adhesive is a plastomer wherein said plastomer is a random copolymer of ethylene or propylene and one or more C 2 to C 12 α-olefin co-monomers and wherein said plastomer has a density as measured according to ISO1183 of between 860 and 930 kg/m 3.
A central terminal for transmission of signals comprising at least m transmission channels and n transmission antennas intended to transmit first signals, with n>m>1, switching means for associating with each signal transmission channel one antenna from among the n antennas according to a switching schema selected by control means, characterized in that, the transmission antennas are directive antennas, each transmission antenna being able to transmit first signals in a predetermined angular sector, and that it comprises a transmission circuit able to transmit via at least one of the directive antennas selected for said client terminal, a second signal (S2, S3) called the interrogation signal in a frequency band close to or identical to the predetermined frequency band of the transmission channel, the control means being connected to a return channel transmitting at least one item of information on the reception quality of the signals transmitted by said central terminal, said control means selecting a switching schema according to said at least one item of information.
A medical device for occupying a space within a patient's body, the medical device comprising: a device assembly comprising an enclosed reservoir, a fluid transfer member, and a release section comprising an elongated structure extending into the reservoir, wherein the elongated structure provides a fluid path out of the enclosed reservoir; wherein the enclosed reservoir is fluid impermeable; wherein the fluid transfer member is configured to permit delivery of fluid into the enclosed reservoir to expand the device assembly towards an active profile; a release material located within the reservoir and adapted to compress an exterior of the release section causing the release section to form a physical barrier to prevent fluid flow through the fluid path of the release section and out of the reservoir until reduction of the structural integrity of the release material upon activation of the release material; and wherein the elongated structure is adapted to separate the release material from the fluid path such that the release material remains physically separated from an environment within the patient's body until reduction of the structural integrity of the release material upon activation of the release materials opens the elongated structure to open the fluid path. a device assembly comprising an enclosed reservoir, a fluid transfer member, and a release section comprising an elongated structure extending into the reservoir, wherein the elongated structure provides a fluid path out of the enclosed reservoir; wherein the enclosed reservoir is fluid impermeable; wherein the fluid transfer member is configured to permit delivery of fluid into the enclosed reservoir to expand the device assembly towards an active profile; a release material located within the reservoir and adapted to compress an exterior of the release section causing the release section to form a physical barrier to prevent fluid flow through the fluid path of the release section and out of the reservoir until reduction of the structural integrity of the release material upon activation of the release material; and wherein the elongated structure is adapted to separate the release material from the fluid path such that the release material remains physically separated from an environment within the patient's body until reduction of the structural integrity of the release material upon activation of the release materials opens the elongated structure to open the fluid path.
An ignition device configured to facilitate ignition of a flame producing assembly comprising a wand, comprising: a receiving portion configured to receive a flame producing assembly comprising a wand, wherein the receiving portion is configured to adapt between a receiving position and an ignition position; a trigger mechanism configured to ignite the flame producing assembly when actuated; characterised in that the ignition device further comprises: a movable pin, wherein the movable pin is configured to move from a first position to a second position when a flame producing assembly comprising a wand is inserted into the receiving portion and the receiving portion is adapted to the ignition position, and wherein the movable pin is further configured to block actuation of the trigger mechanism when in the first position, and configured to allow actuation of the trigger mechanism when in the second position. a receiving portion configured to receive a flame producing assembly comprising a wand, wherein the receiving portion is configured to adapt between a receiving position and an ignition position; a trigger mechanism configured to ignite the flame producing assembly when actuated; characterised in that the ignition device further comprises: a movable pin, wherein the movable pin is configured to move from a first position to a second position when a flame producing assembly comprising a wand is inserted into the receiving portion and the receiving portion is adapted to the ignition position, and wherein the movable pin is further configured to block actuation of the trigger mechanism when in the first position, and configured to allow actuation of the trigger mechanism when in the second position.
Plate stacking device (1; 101) comprising a vertical column (2; 102) with side faces (4A, 4B; 103), one or more of the side faces being provided with plate supports (3; 104), wherein each plate support comprises two upper projections (5; 105) horizontally in line with each other, and a lower projection (6; 106) which is longer than the two upper projections and which lies at a distance below the two upper projections, characterized in that the upper projections (5; 105) projecting from a side face (4A, 4B; 103) are lateral extensions of adjacent column walls (4A, 4B; 116, 117).
LEDs projector providing a body comprising a horizontal support plane on which a motherboard is mounted, a plurality of LEDs being arranged to form a horizontal, flat matrix mounted on said motherboard characterized in that it further comprises strips of lenses separably engageable on the motherboard and superimposed on rows of LEDs, said strips of lenses comprising a housing in each lens covering a respective LED, a plurality of sheets protruding with respect to the horizontal support plane, each sheet being arranged following the whole length of each strip, each sheet being suitable for reflecting light of the LEDs at a predetermined angle.
A pollution mask comprising: an air chamber; a filter which forms a boundary directly between the air chamber and the ambient surroundings outside the air chamber; a fan for drawing air from outside the air chamber into the air chamber and/or drawing air from inside the air chamber to the outside; a means (34, 36) for determining a rotation speed of the fan; and a controller which is adapted to: derive a pressure or detect a pressure change in the air chamber from the rotation speed of the fan in that the fan speed is used as a proxy of pressure measurement such that no additional sensors are required; and determine whether the mask is worn or not based on the derived pressure or pressure change. an air chamber; a filter which forms a boundary directly between the air chamber and the ambient surroundings outside the air chamber; a fan for drawing air from outside the air chamber into the air chamber and/or drawing air from inside the air chamber to the outside; a means (34, 36) for determining a rotation speed of the fan; and a controller which is adapted to: derive a pressure or detect a pressure change in the air chamber from the rotation speed of the fan in that the fan speed is used as a proxy of pressure measurement such that no additional sensors are required; and determine whether the mask is worn or not based on the derived pressure or pressure change. derive a pressure or detect a pressure change in the air chamber from the rotation speed of the fan in that the fan speed is used as a proxy of pressure measurement such that no additional sensors are required; and determine whether the mask is worn or not based on the derived pressure or pressure change.
Compression bandage comprising a first nonwoven layer and at least a second nonwoven layer which is connected to the first nonwoven layer in a planar manner, the two nonwoven layers (1,2) being interconnected by means of a stitch-bonding process via an elastic sewing thread, characterized in that superabsorbent fibers are provided in the first nonwoven layer.
A method for verifying, by means of a smartphone, a phosphor-based security feature containing a phosphor that can be excited to emission and that has a decay time in the ms range, comprising the steps: - exciting the phosphor of the security feature to emission by means of an illumination unit of the smartphone; - capturing the emission upon completion of the excitation during a predetermined decay time through capture of a series of images or of a video recording with an image capture unit of the smartphone; - evaluating the series of images or video recording by means of a data processing unit of the smartphone, wherein the emission captured during the decay time is compared with stored reference data in order to verify the authenticity of the security feature; characterized in that the distance between the security feature and the image capture unit of the smartphone during the excitation of the phosphor and the capture of the emission is selected to be less than the range of focus of the image capture unit. - exciting the phosphor of the security feature to emission by means of an illumination unit of the smartphone; - capturing the emission upon completion of the excitation during a predetermined decay time through capture of a series of images or of a video recording with an image capture unit of the smartphone; - evaluating the series of images or video recording by means of a data processing unit of the smartphone, wherein the emission captured during the decay time is compared with stored reference data in order to verify the authenticity of the security feature;
A washing machine comprising: a cabinet having a first opening and having a washing space formed therein; and a door assembly provided to open and close the first opening, wherein the door assembly includes: a door body having a second opening, a door glass having a hole in the door glass, and a guide duct configured to connect the second opening to the hole; wherein a sealing member is arranged around the perimeter of the hole, wherein the hole and the guide duct are coupled by the sealing member, characterised in that the sealing member includes a sealing cap having one end connected with the guide duct and covering one end of the guide duct. a cabinet having a first opening and having a washing space formed therein; and a door assembly provided to open and close the first opening, wherein the door assembly includes: a door body having a second opening, a door glass having a hole in the door glass, and a guide duct configured to connect the second opening to the hole; wherein a sealing member is arranged around the perimeter of the hole, wherein the hole and the guide duct are coupled by the sealing member, characterised in that the sealing member includes a sealing cap having one end connected with the guide duct and covering one end of the guide duct. a door body having a second opening, a door glass having a hole in the door glass, and a guide duct configured to connect the second opening to the hole; wherein a sealing member is arranged around the perimeter of the hole, wherein the hole and the guide duct are coupled by the sealing member, characterised in that the sealing member includes a sealing cap having one end connected with the guide duct and covering one end of the guide duct.
A tire having a tread comprising a rubber composition based on at least: - an elastomer matrix comprising 5 to 95 phr of a first diene elastomer bearing at least one SiOR function, R being a hydrogen atom or a hydrocarbon radical, the SiOR function not located at the chain ends of the first diene elastomer, and 5 to 95 phr of a second diene elastomer which is a polyisoprene; and - a reinforcing filler comprising more than 45 phr of a reinforcing inorganic filler; wherein the reinforcing filler further comprises greater than 0 phr and less than 10 phr of carbon black. - an elastomer matrix comprising 5 to 95 phr of a first diene elastomer bearing at least one SiOR function, R being a hydrogen atom or a hydrocarbon radical, the SiOR function not located at the chain ends of the first diene elastomer, and 5 to 95 phr of a second diene elastomer which is a polyisoprene; and - a reinforcing filler comprising more than 45 phr of a reinforcing inorganic filler; wherein the reinforcing filler further comprises greater than 0 phr and less than 10 phr of carbon black.
A compound of formula: wherein: is a substituted or unsubstituted N-containing monocyclic, bicyclic or tricyclic heteroraryl; R 1 is H, an alkyl optionally substituted with one or two groups R 6 or an aryl optionally substituted with one or more groups R 6; R 2 is H or alkyl; or R 1 and R 2 are bound together to form a 5- or 6-membered heterocycle; R 3 and R 4 are each independently H or an alkyl optionally substituted with one or two groups R 6; or R 3 and R 4 are bound together to form a 5- to 8-membered heterocycle; R 5 is H, a halogen, an alkyl optionally substituted with 1 or 2 groups R 6, or an alkoxy optionally substituted with 1 or 2 groups R 6; or R 4 and R 5 are bound together to form a 5- to 7-membered heterocyle; R 6 is hydroxy, alkoxy, -NR 15 R 16, -CO-Y-R 17, -CN, -CF 3, or aryl; R 15 and R 16 are each independently H, alkyl, -CO-alkyl or form together with the nitrogen atom a 3- to 6-membered cyclic group; Y is -O- or -NR 18 -; R 17 is H or alkyl; and R 18 is H, alkyl or hydroxyalkyl; provided that when R 3 is H and R 4 and R 5 are bound together to form a 5-membered heterocycle, then R 1 is not H; or a pharmaceutically acceptable salt thereof. is a substituted or unsubstituted N-containing monocyclic, bicyclic or tricyclic heteroraryl; R 1 is H, an alkyl optionally substituted with one or two groups R 6 or an aryl optionally substituted with one or more groups R 6; R 2 is H or alkyl; or R 1 and R 2 are bound together to form a 5- or 6-membered heterocycle; R 3 and R 4 are each independently H or an alkyl optionally substituted with one or two groups R 6; or R 3 and R 4 are bound together to form a 5- to 8-membered heterocycle; R 5 is H, a halogen, an alkyl optionally substituted with 1 or 2 groups R 6, or an alkoxy optionally substituted with 1 or 2 groups R 6; or R 4 and R 5 are bound together to form a 5- to 7-membered heterocyle; R 6 is hydroxy, alkoxy, -NR 15 R 16, -CO-Y-R 17, -CN, -CF 3, or aryl; R 15 and R 16 are each independently H, alkyl, -CO-alkyl or form together with the nitrogen atom a 3- to 6-membered cyclic group; Y is -O- or -NR 18 -; R 17 is H or alkyl; and R 18 is H, alkyl or hydroxyalkyl; provided that when R 3 is H and R 4 and R 5 are bound together to form a 5-membered heterocycle, then R 1 is not H; or a pharmaceutically acceptable salt thereof.